P-429 - TWO-YEAR EXPERIENCE OF PROTONTHERAPY IN PEDIATRIC CANCER PATIENTS
P-430 - ULTRAHYPOFRACTIONATION IN POSTOPERATIVE RADIOTHERAPY FOR BREAST CANCER
p-431 - Ultrahypofractionation with SIB in early breast cáncer: clinical implementation
P-432 - UPDATE ON SURVIVAL AND TOXICITY IN BILATERAL BREAST CANCER
P-433 - USE OF RESPIRATORY MOTION CONTROL IN CARDIAC RADIOABLATION
P-434 - USEFULNESS AND HEALTHCARE COST OF TUMOR MARKERS IN BREAST CANCER
P-435 - VALIDATION OF A VIRTUAL CONE FOR IRRADIATION OF TRIGEMINAL NEURALGIA
P-436 - VALIDATION OF AN EPID-BASED SYSTEM FOR PATIENT-SPECIFIC QUALITY ASSURANCE
P-437 - VALOR DEL PET/TC-PSMA EN LA DECISIÓN TERAPÉUTICA DEL MCPRC
P-438 - Variability in bladder volume in prostate cancer radiotherapy.
P-439 - VASCULAR ASSESSEMENT FOR RADIOTHERAPY PLANNING: PROSPECTIVE STUDY WITH 4D-MRI-FLOW
P-440 - VMAT AS HIGH-PRECISION TECHNIQUE TREATING ESOPHAGEAL CANCER
P-441 - VMAT VERSUS 3DCRT IN ADJUVANT BREAST CANCER TREATMENT
P-442 - VOLUME-BASED VERSUS A-POINT-BASED DOSIMETRY IN BRACHYTHERAPY FOR CERVICAL CANCER
P-443 - WEB SYSTEM FOR REGISTRATION-NOTIFICATION INCIDENTS: IMPLEMENTATION, RESULTS AND SELF-LEARNING.
P-444 - WEEKLY ULTRAFRACTIONATED RADIATION THERAPY FOR BLADDER CANCER IN THE ELDER.
P-445 - Whole lung irradiation in paediatric Ewing’s Sarcoma: a questionable indication?
P-446 - WHOLE-BRAIN RADIOTHERAPY WITH HIPPOCAMPAL AVOIDANCE IN THREE CLINICAL SCENARIOS
P-447 - WHOLE-EXOME SEQUENCING ANALYSIS OF RADIOTHERAPY-INDUCED-RECTAL BLEEDING IN PROSTATE CANCER
P-448 - WHY RADIOTHERAPY PATIENTS COME TO THE EMERGENCY ROOM
P-449 - WHY RADIOTHERAPY PATIENTS ENTER THE HOSPITAL